Bloomberg Podcasts
Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos

The rise of the Ozempic menu: An unexpected restaurant trend

Posted

January 12, 2026

Views

567

Likes

9

Engagement

1.59%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Ozempic and similar weight loss drugs, known as GLP-1s, make people less hungry, but they don't seem to stop them from going out to eat.

Bloomberg Businessweek’s Deena Shanker joins Stacey Vanek Smith and Max Chafkin on the Everybody's Business podcast to unpack this new phenomenon and why the weight loss drug craze is actually benefiting the restaurant industry.

Guests & Subjects Covered

The rise of the Ozempic menuBloomberg Businessweeks Deena ShankerStacey Vanek SmithMax ChafkinEverybody's Business

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

The rise of the Ozempic menu: An unexpected restaurant trend · Bloomberg Podcasts · Sentinel